{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:26:21Z","timestamp":1772889981344,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.rdc.2005.01.006","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T11:37:19Z","timestamp":1117193839000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Inflammation and Accelerated Atherosclerosis: Basic Mechanisms"],"prefix":"10.1016","volume":"31","author":[{"given":"Andrea","family":"Doria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaniv","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier L.","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2005.01.006_bib1","first-page":"5","article-title":"Atherosclerosis and the immune system: is atherosclerosis an autoimmune disease?","volume":"1","author":"Shoenfeld","year":"2000","journal-title":"Seminars in Clinical Immunology"},{"key":"10.1016\/j.rdc.2005.01.006_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1471-4906(01)01922-6","article-title":"Atherosclerosis as an infectious, inflammatory and autoimmune disease","volume":"22","author":"Shoenfeld","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.rdc.2005.01.006_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/ard.61.2.97","article-title":"Atherosclerosis: is atherosclerosis a cellular or humoral mediated autoimmune disease?","volume":"61","author":"Sherer","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2005.01.006_bib4","first-page":"112","article-title":"Inflammatory and immune aspects of atherosclerosis","volume":"1","author":"George","year":"1999","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.rdc.2005.01.006_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory condition","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.01.006_bib6","first-page":"675","article-title":"Inhibition of atherosclerosis in CD4 T-cell-depleted and nude (nu\/nu) C57BL\/6 hyperlipidemic mice","volume":"149","author":"Emeson","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2005.01.006_bib7","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1161\/01.CIR.102.24.2919","article-title":"Transfer of CD4 + T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice","volume":"102","author":"Zhou","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.01.006_bib8","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of \u03b22-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.01.006_bib9","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.102.15.1822","article-title":"Adoptive transfer of beta-2-glycoprotein-I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice","volume":"102","author":"George","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.01.006_bib10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0735-1097(01)01440-1","article-title":"Cellular and humoral immune responses to heat shock protein both involved in promoting fatty-streak formation in LDL-deficient mice","volume":"38","author":"George","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rdc.2005.01.006_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/096120339700600908","article-title":"Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies","volume":"6","author":"George","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2005.01.006_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000028046","article-title":"Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice","volume":"67","author":"Afek","year":"1999","journal-title":"Pathobiology"},{"key":"10.1016\/j.rdc.2005.01.006_bib13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.CIR.98.11.1108","article-title":"Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I","volume":"98","author":"George","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.01.006_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1995.tb06652.x","article-title":"Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotope, subclass, affinity and effect on the macrophage uptake of oxLDL","volume":"102","author":"Wu","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2005.01.006_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.ATV.15.4.441","article-title":"Patients with early onset of peripheral vascular disease have high levels of autoantibodies against oxidized low-density lipoproteins","volume":"15","author":"Bergmark","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rdc.2005.01.006_bib16","unstructured":"Wu R., Shoenfeld Y., Matucci M., et al. Nontraditional factors vary in patients with autoimmune diseases. Clin Invest Med, in press"},{"key":"10.1016\/j.rdc.2005.01.006_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1191\/096120399678847434","article-title":"Antibodies against lysophosphatidylcholine and oxidized LDL in-patients with SLE","volume":"8","author":"Wu","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2005.01.006_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2249.1999.00830.x","article-title":"Antibodies to adult human endothelial cells cross-react with oxidized LDL and \u03b22-glycoprotein I in SLE","volume":"115","author":"Wu","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2005.01.006_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(98)00015-X","article-title":"Hyperimmunization of apo-E mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis","volume":"138","author":"George","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rdc.2005.01.006_bib20","first-page":"2252","article-title":"Are anti-oxLDL antibodies pathogenic or protective?","volume":"110","author":"Wu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.01.006_bib21","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/art.11255","article-title":"Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody","volume":"48","author":"Nicolo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2005.01.006_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2005.01.006_bib23","first-page":"3527","article-title":"Endothelial cells in physiology and in the pathophysiology of vascular disorders","volume":"91","author":"Cines","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2005.01.006_bib24","first-page":"5","article-title":"Endothelial cells present antigens in vivo","volume":"16","author":"Rothermel","year":"2005","journal-title":"BMC Immunol"},{"key":"10.1016\/j.rdc.2005.01.006_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1381612043453441","article-title":"Complement and complement regulatory proteins as potential molecular targets for vascular diseases","volume":"10","author":"Acosta","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.rdc.2005.01.006_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/IR:30:1:073","article-title":"The complement activation in atherosclerosis","volume":"30","author":"Niculescu","year":"2004","journal-title":"Immunol Res"},{"key":"10.1016\/j.rdc.2005.01.006_bib27","series-title":"Atherosclerosis and autoimmunity","first-page":"211","article-title":"Functional heterogeneity of pathogenic anti-endothelial antibodies","author":"Meroni","year":"2001"},{"key":"10.1016\/j.rdc.2005.01.006_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-2478(00)00192-9","article-title":"Antiendothelial cell antibodies in patients with coronary atherosclerosis","volume":"73","author":"George","year":"2000","journal-title":"Immunol Lett"},{"key":"10.1016\/j.rdc.2005.01.006_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0021-9150(00)00482-2","article-title":"Activation of the immune system and coronary artery disease: the role of antiendothelial cell antibodies","volume":"154","author":"Farsi","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rdc.2005.01.006_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0198-8859(99)00056-7","article-title":"Antibodies to human endothelial cells identify myocardial damage and predicts development of coronary artery disease in patients with transplanted hearts","volume":"60","author":"Faulk","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.rdc.2005.01.006_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/clin.1996.0183","article-title":"Upregulation of adhesion molecules on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus","volume":"81","author":"Lai","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.rdc.2005.01.006_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2004.02.015","article-title":"Endothelial cell activation by antiphospholipid antibodies","volume":"112","author":"Meroni","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rdc.2005.01.006_bib33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.01.006_bib34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction. A marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rdc.2005.01.006_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1568-9972(01)00003-9","article-title":"Immunomodulation for treatment and prevention of atherosclerosis","volume":"1","author":"Sherer","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2005.01.006_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08916930400002386","article-title":"The role of DC40\u2013CD154 interactions in autoimmunity and the benefit of disrupting this pathway","volume":"37","author":"Toubi","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rdc.2005.01.006_bib37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0735-1097(02)02135-6","article-title":"Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions","volume":"7","author":"Harats","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rdc.2005.01.006_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1385\/IR:25:3:271","article-title":"Anti-inflammatory and immunomodulatory properties of statins","volume":"25","author":"Shovman","year":"2002","journal-title":"Immunol Res"},{"key":"10.1016\/j.rdc.2005.01.006_bib39","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/cncr.10905","article-title":"Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages","volume":"95","author":"Shapiro","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.rdc.2005.01.006_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/CRIAI:23:3:263","article-title":"Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?","volume":"23","author":"Meroni","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.rdc.2005.01.006_bib41","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI119892","article-title":"Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice","volume":"102","author":"Nicoletti","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2005.01.006_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/0891693031000080228","article-title":"Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations\u2014possible immunomodulation of atherosclerosis","volume":"36","author":"Wu","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rdc.2005.01.006_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0896-8411(99)99999-7","article-title":"Natural antiendothelial cell antibodies (AECA)","volume":"13","author":"Ronda","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1016\/j.rdc.2005.01.006_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2249.2003.02215.x","article-title":"Normal human IgG prevents endothelial cell activation induced by TNF\u03b1 and oxidized low-density lipoprotein atherogenic stimuli","volume":"133","author":"Ronda","year":"2003","journal-title":"Clin Exp Immunol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X05000074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X05000074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:56:42Z","timestamp":1760180202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X05000074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0889857X05000074"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2005.01.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and Accelerated Atherosclerosis: Basic Mechanisms","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2005.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}